Pharmaceuticals
HC blocks Glenmark from selling US firm’s diabetes drug
20 Mar 2015
A bench of Justices S Ravindra Bhat and Najmi Waziri, while granting the interim injunction, said Merck Sharp and Dohme "has established a prima facie case of patent infringement" by Glenmark
MSF flays Gilead’s hepatitis C ‘anti-diversion’ programme
19 Mar 2015
Campaigners have urged Indian generic manufacturers to reject Gilead Sciences’ highly-controversial programme to stop diversion of the drug to western markets, in a move that could compromise people’s treatment and confidentiality
Valeant Pharma raises Salix bid to $11.1 bn
16 Mar 2015
Valeant Pharma plans to raise bid for Salix
14 Mar 2015
Canada’s Valeant Pharmaceuticals International Inc is planning to raise its bid for Salix Pharmaceuticals Ltd, after Endo International Plc tabled a counter-bid this week
Endo International tables $11.2 bn bid for Salix Pharmaceuticals
12 Mar 2015
Ireland-based specialty healthcare company Endo International yesterday offered to buy Salix Pharmaceuticals for around $11.2 billion, trumping an agreed bid by Valeant Pharmaceuticals
